Metabolomics Identifies Perturbations in Human Disorders of Propionate Metabolism

Abstract

Background: We applied untargeted mass spectrometrybased metabolomics to the diseases methylmalonic acidemia (MMA) and propionic acidemia (PA). Methods: We used a screening platform that used untargeted, mass-based metabolomics of methanolextracted plasma to find significantly different molecular features in human plasma samples from MMA and PA patients and from healthy individuals. Capillary reverse phase liquid chromatography (4 L/min) was interfaced to a TOF mass spectrometer, and data were processed using nonlinear alignment software (XCMS) and an online database (METLIN) to find and identify metabolites differentially regulated in disease. Results: Of the approximately 3500 features measured, propionyl carnitine was easily identified as the best biomarker of disease (P value 1.3 ؋ 10 ؊18 ), demonstrating the proof-of-concept use of untargeted metabolomics in clinical chemistry discovery. Five additional acylcarnitine metabolites showed significant differentiation between plasma from patients and healthy individuals, and ␥-butyrobetaine was highly increased in a subset of patients. Two acylcarnitine metabolites and numerous unidentified species differentiate MMA and PA. Many metabolites that do not appear in any public database, and that remain unidentified, varied significantly between normal, MMA, and PA, underscoring the complex downstream metabolic effects resulting from the defect in a single enzyme. Conclusions: This proof-of-concept study demonstrates that metabolomics can expand the range of metabolites

N8‐acetylspermidine as a potential plasma biomarker for Snyder‐Robinson syndrome identified by clinical metabolomics

“…emerge as a powerful tool for the identification of novel biomarkers and distinct metabolic profiles in IEM (Wikoff et al 2007;Shlomi et al 2009;Moco et al 2013).…”

Untargeted metabolomic analysis of urine samples in the diagnosis of some inherited metabolic disorders

“…It has also become an important tool in clinical research and in the diagnosis of human diseases 1,2 . The first attempt to use metabolomic tools in diagnosing inherited metabolic disorders (IMDs) was conducted by Gary Siuzdak´s group 3 . These authors applied an untargeted metabolomic approach using reverse phase capillary liquid chromatography -time-of-flight mass spectrometry based on exact mass measurements and automatic data processing.…”

Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry

“…Mass spectrometric techniques, including liquid chromatography--mass spectrometry (LC/ MS) (Allen et al 2003;Buchholz et al 2001;De Vos et al 2007;Wikoff et al 2007), gas chromatography--mass spectrometry (GC/MS) (Denkert et al 2006;Jones et al 2007; Lee et al 2007), and capillary electrophoresis--mass spectrometry (CE/MS) (Sato et al 2004;Soga et al 2006) are among the analytical techniques currently used in metabolomics research. These mass spectrometric techniques commonly use up-front separation steps to reduce the sample complexity and reduce suppression effects, thereby enhancing the detection sensitivity.…”